AIM: To evaluate the clinical outcomes of the retrogasserian opioid application in patients with type 1 trigeminal neuralgia. MATERIAL and METHODS: A total of 37 patients (12 male, 25 female; average age 56.2 ± 5.4 years) who were administered retrogasserian opioid due to type 1 trigeminal neuralgia between February 2012 and May 2015 were included in the study. A visual analogue scale was used to evaluate pain at the last preoperative and postoperative visits (median follow-up period: 13 months, mean follow-up period: 15.6 months). All parameters were analysed using Wilcoxon signed-rank and Mann-Whitney U tests, with p < 0.05 considered statistically significant. RESULTS: Visual analogue scale scores of all 37 patients were significantly improved in the postoperative period. The average visual analogue scale scores were 7.9 ± 0.62 preoperatively and 2.9 ± 0.5 postoperatively. All changes were statistically significant. CONCLUSION: Percutaneous retrogasserian opioid injection in type 1 trigeminal neuralgia is an effective and safe method of pain control. © 2019, Turkish Neurosurgical Society.
Eser Adı (dc.title) | Evaluation of the retrogasserian opioid application in the treatment of idiopathic trigeminal neuralgia |
Yayın Türü (dc.type) | Makale |
Yazar/lar (dc.contributor.author) | İLİK, Mustafa Kemal |
Yazar/lar (dc.contributor.author) | İLİK, Faik |
DOI Numarası (dc.identifier.doi) | 10.5137/1019-5149.JTN.22604-18.2 |
Atıf Dizini (dc.source.database) | Scopus |
Yayıncı (dc.publisher) | Turkish Neurosurgical Society |
Yayın Tarihi (dc.date.issued) | 2019 |
Kayıt Giriş Tarihi (dc.date.accessioned) | 2020-08-07T12:51:45Z |
Açık Erişim tarihi (dc.date.available) | 2020-08-07T12:51:45Z |
Kaynak (dc.source) | Turkish Neurosurgery |
ISSN (dc.identifier.issn) | 10195149 (ISSN) |
Özet (dc.description.abstract) | AIM: To evaluate the clinical outcomes of the retrogasserian opioid application in patients with type 1 trigeminal neuralgia. MATERIAL and METHODS: A total of 37 patients (12 male, 25 female; average age 56.2 ± 5.4 years) who were administered retrogasserian opioid due to type 1 trigeminal neuralgia between February 2012 and May 2015 were included in the study. A visual analogue scale was used to evaluate pain at the last preoperative and postoperative visits (median follow-up period: 13 months, mean follow-up period: 15.6 months). All parameters were analysed using Wilcoxon signed-rank and Mann-Whitney U tests, with p < 0.05 considered statistically significant. RESULTS: Visual analogue scale scores of all 37 patients were significantly improved in the postoperative period. The average visual analogue scale scores were 7.9 ± 0.62 preoperatively and 2.9 ± 0.5 postoperatively. All changes were statistically significant. CONCLUSION: Percutaneous retrogasserian opioid injection in type 1 trigeminal neuralgia is an effective and safe method of pain control. © 2019, Turkish Neurosurgical Society. |
Yayın Dili (dc.language.iso) | en |
Tek Biçim Adres (dc.identifier.uri) | http://hdl.handle.net/20.500.12498/2811 |